Adrestia Therapeutics
Eugene Gardner has held various roles throughout their work experience. Eugene started their career as a Laboratory Technician at Carnegie Institution for Science from September 2010 to August 2012. Eugene then worked as a Postdoctoral Researcher at Wellcome Sanger Institute from May 2017 to May 2021. Afterwards, they joined MRC Epidemiology Unit as a Research Associate from May 2021 to July 2022. Currently, they are working at Adrestia Therapeutics as a Principal Scientist starting from July 2022.
Eugene Gardner obtained a Bachelor of Science (BS) degree in Microbiology, General from Ohio University between the years of 2006 and 2010. Following this, they pursued a Doctor of Philosophy (PhD) degree in Genome Sciences/Genomics at the University of Maryland, Baltimore (UMB) from 2012 to 2017.
Adrestia Therapeutics
Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.